Acute rheumatic fever is a systemic inflammatory disease that develops as an immune-mediated complication of streptococcal infection and affects connective tissue, primarily involving the heart, joints, skin, and central nervous system. The condition most commonly occurs in children and young adults and requires timely, comprehensive treatment to prevent severe complications.
When is treatment required?
Treatment is required in the presence of joint pain and swelling, elevated body temperature, general weakness, skin rashes, as well as signs of cardiac involvement such as shortness of breath, palpitations, and chest pain. Indications for initiating therapy include a confirmed association of symptoms with a recent streptococcal infection and evidence of active inflammatory processes.
How is treatment carried out?
Treatment of acute rheumatic fever is aimed at suppressing inflammation, eliminating the consequences of streptococcal infection, and preventing cardiac damage. Pharmacological therapy is selected based on clinical manifestations and the degree of disease activity. Regular monitoring of laboratory parameters and cardiovascular status is performed. After the acute phase, long-term follow-up and preventive therapy are prescribed to reduce the risk of recurrence.
Main advantages of treating acute rheumatic fever in Belarus
Comprehensive diagnostics are carried out with assessment of inflammatory activity and evaluation of internal organ involvement. An individualized, stepwise treatment approach helps reduce the risk of complications, prevent chronic heart damage, and ensure stable patient recovery.
Acute rheumatic fever can be effectively treated with timely medical care, which is available in leading clinics in Belarus, where modern diagnostic methods, evidence-based therapy, and structured long-term patient monitoring are provided.
